Besides glucose homeostasis controlling, GLP-1 increased AKT, ERK, and eNOS signaling to activate survival pathway, which were associated with the outcome improvement after myocardial infarction [13], [41]. The gene discussed is GLP1R; the disease is myocardial infarction.